Predictors of no-reflow after coronary stenting in patients with high thrombus burden

Yıl 2025, Cilt: 8 Sayı: 2, 345 - 349, 21.03.2025

Ufuk Yıldırım , Metin Çoksevim , Abdulkadir Kara , Alperen Altınbaş , Meliyke Hatun Başer

https://doi.org/10.32322/jhsm.1611566

Öz

Aims: In this study, we aimed to reveal the predictors of no-reflow after coronary stenting in patients with high thrombus burden.
Methods: Patients with acute myocardial infarction who underwent stenting of a coronary lesion with high thrombus burden in the same session between February 2020 and July 2022 in our center were included in this retrospective study. High thrombus burden was accepted as Thrombolysis in Myocardial Infarction (TIMI) grade 4 or 5 thrombus. No-reflow was accepted as TIMI grade ≤2 flow at the end of the procedure. Multivariate logistic regression analysis was executed to ascertain the predictors of no-reflow.
Results: Of the 485 patients included in the study, 407 (83.9%) did not develop no-reflow. Of the 78 (16.1%) patients who developed no-reflow at the end of the procedure, 61 had TIMI 2, 10 had TIMI 1, and 7 had TIMI 0 flow. Age [odds ratio (OR) 1.051; 95% confidence interval (CI) 1.021-1.082; p=.001], accumulated thrombus proximal to the occlusion (OR 3.318; 95% CI 1.176-9.365; p=.023), reference vessel diameter (RVD) greater than 4 mm (OR 2.569; 95% CI 1.005-6.565; p=.049), and TIMI flow grade after wiring or small balloon dilation (OR 0.108; 95% CI 0.065-0.181; p<.001) were the independent predictors of no-reflow.
Conclusion: Older age, accumulated thrombus proximal to the occlusion, RVD greater than 4 mm, and the absence of TIMI grade 3 flow after wiring or small balloon dilation may be associated with an increased risk of no-reflow after coronary stenting in patients with high thrombus burden.

Anahtar Kelimeler

No-reflow, coronary stenting, high thrombus burden

Yüksek trombüs yükü olan hastalarda koroner stentleme sonrası no-reflow gelişiminin prediktörleri

Öz

Amaçlar: Bu çalışmada, yüksek trombüs yükü olan hastalarda koroner stentleme sonrası no-reflow gelişiminin öngörücülerini ortaya koymayı amaçladık.
Yöntemler: Merkezimizde Şubat 2020 ile Temmuz 2022 tarihleri arasında yüksek trombüs yükü olan koroner lezyonuna aynı seansta stentleme yapılan hastalar bu retrospektif çalışmaya dahil edildi. Yüksek trombüs yükü TIMI derece 4 veya 5 trombüs olarak kabul edildi. No-reflow işlem sonunda TIMI derece ≤2 akım olarak kabul edildi. No-reflow gelişiminin öngörücülerini tespit etmek için çok değişkenli lojistik regresyon analizi yapıldı.
Bulgular: Çalışmaya dahil edilen 485 hastanın 407'sinde (%83,9) no-reflow gelişmemişti. İşlem sonunda no-reflow gelişen 78 (%16,1) hastanın 61'inde TIMI 2, 10'unda TIMI 1, 7'sinde TIMI 0 akım mevcuttu. Yaş [odds oranı (OO) 1,051; %95 güven aralığı (GA) 1,021-1,082; P = ,001], oklüzyon proksimalinde birikmiş trombüs (OO 3,318; %95 GA 1,176-9,365; P = ,023), referans damar çapının (RDÇ) 4 mm'den büyük olması (OO 2,569; %95 GA 1,005-6,565; P = ,049) ve telleme veya küçük balonla dilatasyon sonrası TIMI akım derecesi (OO 0,108; %95 GA 0,065-0,181; P <,001) no-reflow gelişiminin bağımsız öngörücüleriydi.
Sonuç: İleri yaş, oklüzyon proksimalinde birikmiş trombüs, 4 mm'den büyük RDÇ ve telleme veya küçük balonla dilatasyon sonrası TIMI derece 3 akımın olmaması yüksek trombüs yükü olan hastalarda koroner stentleme sonrası artmış no-reflow riski ile ilişkili olabilir.

Anahtar Kelimeler

No-reflow, koroner stentleme, yüksek trombüs yükü

Kaynakça

• Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J. 2001;22(9):729-739.
• Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007;99(4):442-445. doi:10.1016/j.amjcard.2006.08.054
• Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002; 105(16):1909-1913. doi:10.1161/01.cir.0000014683.52177.b5
• Bolognese L, Carrabba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004;109(9):1121-1126. doi:10.1161/01.CIR.0000 118496.44135.A7
• Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97(8):765-772. doi: 10.1161/01.cir.97.8.765
• Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21): 2550-2554. doi:10.1161/01.cir.103.21.2550
• Stevens PE, Levin A; kidney disease: improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-830. doi:10.7326/0003-4819-158-11-201306040-00007
• Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest. 2002;122(4):1322-1332. doi:10.1378/chest.122.4.1322
• Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis. Indian Heart J. 2018;70(Suppl 3):S406-S418. doi:10.1016/j.ihj.2018.01.032
• Refaat H, Tantawy A, Gamal AS, Radwan H. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Indian Heart J. 2021;73(1):35-43. doi:10.1016/j.ihj.2020.12.008
• Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96-102. doi:10.5847/wjem.j.issn.1920-8642.2014.02.003
• Mazhar J, Mashicharan M, Farshid A. Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction. Int J Cardiol Heart Vasc. 2015;10:8-12. doi:10.1016/j.ijcha.2015.11.002
• Kirma C, Izgi A, Dundar C, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008;72(5):716-721. doi:10.1253/circj.72.716
• Cura FA, L’Allier PL, Kapadia SR, et al. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2001;88(2):124-128. doi:10.1016/s0002-9149(01)01605-8
• Sabin P, Koshy AG, Gupta PN, et al. Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from medical college hospital, Trivandrum. Indian Heart J. 2017;69(Suppl 1):S34-S45. doi:10.1016/j.ihj.2016.12.012
• Ruiz-García J, Lerman A, Weisz G, et al. Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study. EuroIntervention. 2012;8(8):929-938. doi:10.4244/EIJV8I8A142
• Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24(2):471-476. doi:10.1016/0735-1097 (94)90305-0
• Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54(4):281-292. doi:10.1016/j.jacc.2009. 03.054
• Brilakis E. Chapter 20: Acute coronary syndromes−thrombus. In: Brilakis E, ed. Manual of percutaneous coronary interventions: a step-by-step approach. Elsevier. 2020;351-361.
• Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes. Diab Vasc Dis Res. 2005;2(3):136-143. doi:10.3132/dvdr.2005.021
• Nair Rajesh G, Jayaprasad N, Madhavan S, et al. Predictors and prognosis of no-reflow during primary percutaneous coronary intervention. Proc (Bayl Univ Med Cent). 2018;32(1):30-33. doi:10.1080/08998280.2018.1509577